J&J Agrees to Pay $22.9 Million to Settle on Drug Recalls

Johnson & Johnson, the world’s largest maker of health-care products, agreed to pay $22.9 million to settle a lawsuit claiming it misled investors about quality-control failures that led to recalls, according to court papers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.